Talat Imran

CIK: 0001869579

Transaction Breakdown

Open Market Buys (P)2 (16.7%)

High conviction signal

Open Market Sales (S)1 (8.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)7 (58.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RANI

Rani Therapeutics Holdings, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

RANI
Rani Therapeutics Holdings, Inc.
Sep 27, 2026
Tax Payment(F)
Direct
7.9K shares at avg. $0.76$6K
RANI
Rani Therapeutics Holdings, Inc.
Jul 17, 2026
Purchase(P)
Direct
35K shares at avg. $0.72$25K
RANI
Rani Therapeutics Holdings, Inc.
Jun 27, 2026
Tax Payment(F)
Direct
7.9K shares at avg. $0.74$6K
RANI
Rani Therapeutics Holdings, Inc.
Jun 3, 2026
Award(A)
Stock Option (Right to Buy)
Direct
3.8M shares-
RANI
Rani Therapeutics Holdings, Inc.
Mar 27, 2026
Tax Payment(F)
Direct
9.1K shares at avg. $0.81$7K
RANI
Rani Therapeutics Holdings, Inc.
Mar 22, 2026
Tax Payment(F)
Direct
8.9K shares at avg. $1.13$10K
RANI
Rani Therapeutics Holdings, Inc.
Dec 27, 2025
Tax Payment(F)
Direct
7.9K shares at avg. $1.40$11K
RANI
Rani Therapeutics Holdings, Inc.
Sep 27, 2025
Tax Payment(F)
Direct
9.1K shares at avg. $0.48$4K
RANI
Rani Therapeutics Holdings, Inc.
Jun 27, 2025
Tax Payment(F)
Direct
9.1K shares at avg. $0.55$5K
RANI
Rani Therapeutics Holdings, Inc.
May 23, 2025
Award(A)
Stock Option (Right to Buy)
Direct
1.1M shares-
RANI
Rani Therapeutics Holdings, Inc.
Dec 27, 2024
Sale(S)
Direct
8K shares at avg. $1.41$11K
RANI
Rani Therapeutics Holdings, Inc.
Dec 9, 2024
Purchase(P)
Direct
10.3K shares at avg. $1.94$20K

		Type	Shares	Price		Ownership
Sep 27, 2026	RANI Rani Therapeutics Holdings, Inc.	Tax Payment(F)	7,928	$0.76	$6,019	Direct
Jul 17, 2026	RANI Rani Therapeutics Holdings, Inc.	Purchase(P)	35,000	$0.72	$25,193	Direct
Jun 27, 2026	RANI Rani Therapeutics Holdings, Inc.	Tax Payment(F)	7,927	$0.74	$5,866	Direct
Jun 3, 2026	RANI Rani Therapeutics Holdings, Inc.	Award(A) Stock Option (Right to Buy)	3,800,000	-	-	Direct
Mar 27, 2026	RANI Rani Therapeutics Holdings, Inc.	Tax Payment(F)	9,099	$0.81	$7,370	Direct
Mar 22, 2026	RANI Rani Therapeutics Holdings, Inc.	Tax Payment(F)	8,916	$1.13	$10,075	Direct
Dec 27, 2025	RANI Rani Therapeutics Holdings, Inc.	Tax Payment(F)	7,906	$1.40	$11,068	Direct
Sep 27, 2025	RANI Rani Therapeutics Holdings, Inc.	Tax Payment(F)	9,077	$0.48	$4,357	Direct
Jun 27, 2025	RANI Rani Therapeutics Holdings, Inc.	Tax Payment(F)	9,076	$0.55	$4,992	Direct
May 23, 2025	RANI Rani Therapeutics Holdings, Inc.	Award(A) Stock Option (Right to Buy)	1,053,000	-	-	Direct
Dec 27, 2024	RANI Rani Therapeutics Holdings, Inc.	Sale(S)	8,014	$1.41	$11,300	Direct
Dec 9, 2024	RANI Rani Therapeutics Holdings, Inc.	Purchase(P)	10,296	$1.94	$19,974	Direct

1-12 of 12 transactions

About Imran Talat

Imran Talat (SEC CIK 0001869579) files insider reports with the SEC as Chief Executive Officer of Rani Therapeutics Holdings, Inc. (RANI).

Signal8 holds 6 ownership filings by Imran Talat, all Form 4s, filed between Dec 10, 2024 and Sep 29, 2026. Those filings report 12 transactions, from Dec 9, 2024 to Sep 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Imran Talat's filings is in SAN JOSE, CA.

Recent filings by Imran Talat

Sep 27, 2026: Tax withholding of RANI shares (Form 4, code F).
Jul 17, 2026: Open-market purchase of RANI shares (Form 4, code P).
Jun 27, 2026: Tax withholding of RANI shares (Form 4, code F).
Jun 3, 2026: Grant or award of RANI derivative securities (Form 4, code A).
Mar 27, 2026: Tax withholding of RANI shares (Form 4, code F).

Other insiders filing for Rani Therapeutics Holdings, Inc. (RANI)

Javadi Alireza, Chief Technical Officer
Gilson Michelle, Director
IMRAN MIR A, Director
Maestas Nicholas, Chief Financial Officer
McKinley Kate, Chief Business Officer
Bassan Abraham, Director

How to read Form 4 transaction codes